AbbVie

ABBV · United States · Biotechnology · matched S&P 500 member. Follow its market-weight contribution.

Historical time machine

Historical observation

20182026

Universe weight

0.680%

12M weight contribution

+0.028 pp

3M weight contribution

+0.089 pp

12M price return

+9.7%

Share of matched S&P 500 members

Monthly observations through Apr 2020

Company price index

A separate dimension from market allocation

Historical observations

Most recent 24 observations at or before the selected month

Month	Market cap	Universe weight	12M weight change	12M return	Above 6M weight average
Apr 2020	$121.6bn	0.680%	+0.028 pp	+9.7%	Yes
Mar 2020	$112.7bn	0.001%	-0.682 pp	+0.0%	No
Feb 2020	$126.8bn	0.001%	-0.677 pp	+14.4%	No
Jan 2020	$119.8bn	0.591%	+0.193 pp	+6.7%	No
Dec 2019	$130.9bn	0.642%	+0.147 pp	+1.5%	Yes
Nov 2019	$129.7bn	0.654%	+0.182 pp	-1.7%	Yes
Oct 2019	$117.6bn	0.613%	+0.213 pp	+8.0%	Yes
Sep 2019	$112.0bn	0.595%	+0.138 pp	-15.7%	Yes
Aug 2019	$97.2bn	0.529%	+0.059 pp	-27.9%	No
Jul 2019	$98.5bn	0.524%	-0.330 pp	-24.0%	No
Jun 2019	$107.5bn	0.580%	-0.312 pp	-17.8%	No
May 2019	$113.4bn	0.660%	-0.292 pp	-18.8%	Yes
Apr 2019	$117.1bn	0.652%	-0.290 pp	-13.9%	Yes
Mar 2019	$118.9bn	0.683%	-0.239 pp	-11.1%	Yes
Feb 2019	$116.9bn	0.678%	-0.425 pp	-28.6%	Yes
Jan 2019	$120.8bn	0.398%	-0.624 pp	-25.3%	No
Dec 2018	$138.7bn	0.496%	-0.526 pp	-15.3%	No
Nov 2018	$141.8bn	0.471%	-0.551 pp	-13.3%	No
Oct 2018	$117.9bn	0.400%	-0.622 pp	-28.4%	No
Sep 2018	$143.2bn	0.456%	-0.566 pp	-14.0%	No
Aug 2018	$145.3bn	0.469%	-0.553 pp	-12.7%	No
Jul 2018	$146.4bn	0.854%	-0.168 pp	-16.1%	No
Jun 2018	$147.0bn	0.892%	-0.130 pp	-16.6%	No
May 2018	$157.0bn	0.953%	-0.069 pp	-10.9%	No

Its weight is estimated market cap divided by the total estimated market cap of matched S&P 500 members for the month. This is not an official float-adjusted S&P index weight.